Canton biologics is an international technology-based biopharmaceutical CRDMSO company with seven R&D and manufacturing centers around the world. With proprietary High-Titer cell lines(CHO K1/CHO-DG44/GLYCOEXPRESS, over 20g/L), complex protein high expression ability, and production capacity meeting international standards, we have been highly praised by customers.Our major technological breakthroughs have been made in IgMaxTM Expression Platform, IgMasterTM Process Platform, CHO-Rise® Proprietary expression medium, C-BoostTM Intensified Fed-batch Platform, Formulation technology (Lyophilization, Vaccine, nasal spray, lnhalation, Eye drops and High concentration formulation)and analysis. As a highly efficient company, we have created a new record that from DNA to CMC in only 7 months, which has played an important role in the rapid advancement of customers’ products to clinical practice.In addition, we have 12+4 manufacturing lines complying with China, US and EU GMP standard(50-2000L ,batch, fed-batch, perfusion) for DS and DP manufacturing.